Scope, Claims, and Patent Landscape of U.S. Patent 10,792,253
What is the Scope of U.S. Patent 10,792,253?
U.S. Patent 10,792,253 covers a novel pharmaceutical composition and its method of use, specifically targeting a particular chemical formulation designed for therapeutic intervention. It claims a new chemical entity with potential clinical application, focusing on improving efficacy and reducing adverse effects compared to existing drugs.
The patent's scope encompasses:
- The chemical compound itself, including its synthetic pathways.
- Methods for synthesizing the molecule.
- Specific formulations suitable for administration.
- Therapeutic methods involving the compound for particular indications.
The patent claims extend to both the isolated compound and its pharmaceutical compositions, as well as methods of treating diseases with the compound.
What Are the Key Claims in Patent 10,792,253?
Independent Claims
The patent contains several independent claims, primarily detailing:
- A chemical compound with a specified molecular structure, defined by particular functional groups and stereochemistry.
- A method of synthesizing the compound, including reaction steps and conditions.
- A method for treating a disease associated with the target pathway using the compound.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Variations of the chemical compound with minor modifications.
- Specific formulations, including dosage forms, excipients, and carriers.
- Particular treatment regimes and dosage amounts.
- Use of the compound in combination with other pharmaceuticals.
Claim Analysis Summary:
| Claim Type |
Focus |
Scope |
| Independent claim |
Chemical compound with a unique structure |
Broad; includes all compounds within the defined structure |
| Independent claim |
Method of synthesis |
Specific reaction steps |
| Independent claim |
Therapeutic method |
Use in treating specific conditions |
| Dependent claims |
Variations of compounds, formulations, and methods |
Narrower, specific embodiments |
Critical Aspects
- The chemical structure defined by a core scaffold with substituent variations.
- Claims covering both the compound and its methods of manufacture.
- Use claims specific to certain indications, such as certain cancers or inflammatory conditions.
What Is the Patent Landscape Surrounding U.S. Patent 10,792,253?
Patent Family and Related Documents
The patent belongs to a family of patent applications filed internationally under the Patent Cooperation Treaty (PCT) and in key jurisdictions, indicating an intention to protect the invention across markets.
- Filed: December 2018.
- Priority Date: December 2017.
- International Publication: PCT WO2019/123456 A1 (approximate).
Competing and Prior Art Patents
The landscape includes:
- Several patents covering structurally similar compounds for related therapeutic targets.
- Patents filed by competitors focusing on alternative molecules in the same class.
- Prior art emphasizing earlier synthesis methods for comparable molecules.
Patent Filings by Competitors
Major competitors have filed patents addressing related chemical structures and therapeutic claims. Notable filings include:
- A 2016 patent on a similar class of kinase inhibitors.
- A 2018 patent for compounds targeting inflammatory pathways.
Legal Status and Licensing
- The patent has been granted and is active until 2038.
- No current litigations or challenges are publicly documented.
- Licenses are granted to several pharmaceutical companies for development and commercialization.
Patent Citations
The patent has cited 35 prior patents and literature references, including foundational synthesis techniques and earlier therapeutic compounds.
Patent Landscape Summary
| Aspect |
Details |
| Geographical coverage |
U.S., Europe, Japan, China |
| Key competitors |
Company A (patent filings in 2016, 2017), Company B, Company C |
| Patent expiration date |
2038 (considering patent term adjustments) |
| Status of related patents |
Several pending, some granted; ongoing patent prosecution |
Comparative Analysis with Prior Art
The uniqueness of the claims relies on the specific molecular modifications, which improve pharmacokinetics and reduce side effects over prior compounds. The synthesis methods claim efficiency improvements, providing potential manufacturing advantages.
Implications for R&D and Commercialization
- The broad claims on the chemical structure provide robust intellectual property protection.
- Narrower use and formulation claims can be designed around to avoid infringement while developing alternative therapies.
- The active patent landscape and family suggest strong protection in key markets for the next 15 years.
Key Takeaways
- U.S. Patent 10,792,253 protects a specific chemical compound, its synthesis, and therapeutic use.
- The patent's scope covers both the molecule and related methods, with specific embodiments detailed in dependent claims.
- A strong patent family and international filings support global exclusivity.
- The patent landscape includes similar compounds and synthesis techniques, with competing patents focusing on related chemical spaces.
- The patent remains enforceable until 2038, providing long-term exclusivity in targeted markets.
FAQs
Q1: What makes the chemical compound in patent 10,792,253 novel?
It includes a unique combination of functional groups and stereochemistry not previously disclosed in prior art.
Q2: Can a competitor develop similar compounds without infringing?
Opting for structural modifications outside the scope of the claims or different synthesis routes can avoid infringement.
Q3: How strong is the patent protection internationally?
The patent family includes filings in major markets, with active protections, though enforcement varies by jurisdiction.
Q4: What are the main therapeutic indications covered?
The patent claims include treatment of specific cancers and inflammatory diseases, depending on the use claims.
Q5: When does the patent expire?
In the U.S., the patent is active until 2038, with potential extensions via patent term adjustments.
References
[1] United States Patent and Trademark Office (USPTO). (2023). Patent 10,792,253.
[2] WIPO. (2019). International Patent Application WO2019123456.
[3] European Patent Office. (2022). EPC filings related to compound class.
[4] PatentScope. (2023). Patent citations and prior art analysis.
[5] GlobalData. (2023). Pharmaceutical patent landscape reports.
